title: Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3.
abstract: Salt and water secretion from intestinal epithelia requires enhancement of anion permeability across the apical membrane of Cl- secreting cells lining the crypt, the secretory gland of the intestine. Paneth cells located at the base of the small intestinal crypt release enteric defensins (cryptdins) apically into the lumen. Because cryptdins are homologs of molecules known to form anion conductive pores in phospholipid bilayers, we tested whether these endogenous antimicrobial peptides could act as soluble inducers of channel-like activity when applied to apical membranes of intestinal Cl- secreting epithelial cells in culture. Of the six peptides tested, cryptdins 2 and 3 stimulated Cl- secretion from polarized monolayers of human intestinal T84 cells. The response was reversible and dose dependent. In contrast, cryptdins 1, 4, 5, and 6 lacked this activity, demonstrating that Paneth cell defensins with very similar primary structures may exhibit a high degree of specificity in their capacity to elicit Cl- secretion. The secretory response was not inhibited by pretreatment with 8-phenyltheophyline (1 microM), or dependent on a concomitant rise in intracellular cAMP or cGMP, indicating that the apically located adenosine and guanylin receptors were not involved. On the other hand, cryptdin 3 elicited a secretory response that correlated with the establishment of an apically located anion conductive channel permeable to carboxyfluorescein. Thus cryptdins 2 and 3 can selectively permeabilize the apical cell membrane of epithelial cells in culture to elicit a physiologic Cl- secretory response. These data define the capability of cryptdins 2 and 3 to function as novel intestinal secretagogues, and suggest a previously undescribed mechanism of paracrine signaling that in vivo may involve the reversible formation of ion conductive channels by peptides released into the crypt microenvironment.
authors.affiliation: Combined Program in Pediatric Gastroenterology and Nutrition, Children's Hospital, Boston, MA 02115, USA.
authors.forename: W I
authors.initials: WI
authors.lastname: Lencer
authors.forename: G
authors.initials: G
authors.lastname: Cheung
authors.forename: G R
authors.initials: GR
authors.lastname: Strohmeier
authors.forename: M G
authors.initials: MG
authors.lastname: Currie
authors.forename: A J
authors.initials: AJ
authors.lastname: Ouellette
authors.forename: M E
authors.initials: ME
authors.lastname: Selsted
authors.forename: J L
authors.initials: JL
authors.lastname: Madara
mesh_terms: D000595:Amino Acid Sequence; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001798:Blood Proteins / Q000494:pharmacology*; D002460:Cell Line; D018118:Chloride Channels / Q000378:metabolism*; D002712:Chlorides / Q000378:metabolism*; D023082:Defensins; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D007421:Intestine, Small / Q000378:metabolism; D008969:Molecular Sequence Data; D011506:Proteins / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000890:Anti-Infective Agents; D001798:Blood Proteins; D018118:Chloride Channels; D002712:Chlorides; D023082:Defensins; D011506:Proteins; C107641:cryptdin 2; C107642:cryptdin 3